EGFR and cancer: In addition, core fucosylation facilitates the binding of TGF-β receptors with their ligands in tumor cells and the phosphorylation of epidermal growth factor receptor in cancer-associated fibroblasts, which could promote the formation of epithelial-mesenchymal transition and tumor microenvironment, respectively [16, 44].